DEEP VEIN THROMBOSIS POSTOPERATIVE

This adverse event was reported 1745 times

These drugs are most commonly taken by patients reporting DEEP VEIN THROMBOSIS POSTOPERATIVE:

# Drug Count
0 DICLOFENAC SODIUM 1313
1 DICLOFENAC 1309
2 ADALIMUMAB 1293
3 METHOTREXATE SODIUM 1251
4 FOLIC ACID 1227
5 ALENDRONATE SODIUM 1226
6 TOCILIZUMAB 1226
7 DESOXIMETASONE 1206
8 METHOTREXATE 1192
9 CETIRIZINE HYDROCHLORIDE 1180
See all common drugs associated with DEEP VEIN THROMBOSIS POSTOPERATIVE

DEEP VEIN THROMBOSIS POSTOPERATIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRICLOSAN 106 0.2195
1 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 84 0.1436
2 CAFFEINE CITRATE 271 0.1268
3 NEOMYCIN OINTMENT 270 0.1226
4 DICLOFENAC POTASSIUM TABLETS 887 0.1155
5 HYDROCORTISONE BUTYRATE 191 0.1086
6 DICLOFENAC POTASSIUM 887 0.0885
7 CLEAR MINT, GEL TOOTHPASTE 88 0.0868
8 SODIUM FLUORIDE F18 88 0.0861
9 SODIUM FLUORIDE F-18 88 0.0859
See all drugs enriched for association with DEEP VEIN THROMBOSIS POSTOPERATIVE

DEEP VEIN THROMBOSIS POSTOPERATIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 218 0.0241
1 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 272 0.0145
2 Tetracycline-class Drug [EPC] 793 0.0120
3 Antirheumatic Agent [EPC] 1180 0.0115
4 Interleukin-6 Receptor Antagonist [EPC] 1295 0.0100
5 Interleukin-12 Antagonist [EPC] 963 0.0097
6 Aminosalicylate [EPC] 1199 0.0093
7 Histamine-1 Receptor Antagonist [EPC] 723 0.0092
8 Selective T Cell Costimulation Modulator [EPC] 1067 0.0080
9 Methylxanthine [EPC] 691 0.0078
See all drug classes enriched for association with DEEP VEIN THROMBOSIS POSTOPERATIVE